Live feed
Filing
SC 13D
SC 13D0001193125-22-213610·Kalaris Therapeutics, Inc.
Schedule 13D ownership disclosure
ALLOVIR INC
Security class unavailable · CUSIP: 019818103
Event date: 2022-07-28
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 2.2000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-22-213610
- Form type
- SC 13D
- Filer
- Kalaris Therapeutics, Inc.
- CIK
- CIK 1754068
- Filed
- Aug 05, 2022
- Reporting period
- Jul 28, 2022
- Description
- Schedule 13D beneficial ownership